Same Indication

Nivolumab vs Telmisartan

Nivolumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between Nivolumab and Telmisartan.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Telmisartan β€” 24 hours.

Chemical Properties

Molecular Formula: Telmisartan β€” C33H30N4O2.

Molecular Weight: Telmisartan β€” 514.6230 g/mol.

Type: Nivolumab β€” Antibody; Telmisartan β€” Small molecule.